These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Estimation of the possibilities of using unified chemotherapy regimens in new cases of pulmonary tuberculosis in old-age children and adolescents]. Gubkina MF, Ershova NG. Probl Tuberk Bolezn Legk; 2009; (1):33-6. PubMed ID: 19256010 [Abstract] [Full Text] [Related]
3. [Multidrug pulmonary tuberculosis: sociomedical features and the efficiency of inpatient treatment]. Filiniuk OV, Ianova GV, Strelis AK, Urazova OI, Zemlianaia NA, Buĭnova LN, Voronkova OV, Ianov SA, Shchegertsov DIu. Probl Tuberk Bolezn Legk; 2008; (8):23-8; discussion 28. PubMed ID: 18819334 [Abstract] [Full Text] [Related]
5. [The course of a process and the efficiency of treatment of pulmonary tuberculosis patients excreting Mycobacterium tuberculosis with extensive drug resistance to antituberculous drugs]. Mishin VIu, Komissarova OG, Chukanov VI, Kononets AS. Probl Tuberk Bolezn Legk; 2009; (2):50-2. PubMed ID: 19382643 [Abstract] [Full Text] [Related]
8. [Evaluation of the efficiency of a hospital stage of treatment in delivering antituberculous care to mental patients with active pulmonary tuberculosis]. Borzenko AS, Zubova EIu, Iaitskiĭ IuA. Probl Tuberk Bolezn Legk; 2007; (6):37-40. PubMed ID: 17672060 [Abstract] [Full Text] [Related]
10. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis]. Kang WL, Xie YG, Tan WG, Chu NH, Li L, You YH, Yang YZ, Wang XM, Yan XL, Miao ZP, Duanmu HJ. Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883 [Abstract] [Full Text] [Related]
11. [Results of use of surfactant in complex therapy of patients with destructive pulmonary tuberculosis]. Lovacheva OV, Erokhin VV, Chernichenko NV, Evgushchenko GV, Lepekha LN, Rozenberg OA. Probl Tuberk Bolezn Legk; 2006 Feb; (10):12-7. PubMed ID: 17139825 [Abstract] [Full Text] [Related]
12. [Efficiency of retrosternal lymphotropic chemotherapy in the treatment of new cases of destructive pulmonary tuberculosis]. Kibrik BS, Zakharov AV. Probl Tuberk Bolezn Legk; 2009 Feb; (4):23-7. PubMed ID: 19514450 [Abstract] [Full Text] [Related]
13. [Evaluation of care for elderly pulmonary tuberculosis patients]. Sasaki Y, Yamagishi F, Yagi T, Hashimoto T, Bekku R, Kawasaki T, Shinozaki A. Kekkaku; 2007 Oct; 82(10):733-9. PubMed ID: 18018597 [Abstract] [Full Text] [Related]
14. Prediction of delayed treatment response in pulmonary tuberculosis: use of time to positivity values of Bactec cultures. Carroll NM, Uys P, Hesseling A, Lawrence K, Pheiffer C, Salker F, Duncan K, Beyers N, van Helden PD. Tuberculosis (Edinb); 2008 Nov; 88(6):624-30. PubMed ID: 18456556 [Abstract] [Full Text] [Related]
15. [Individual approaches to complex treatment of disseminated tuberculous processes in adolescents]. Gergert VIa, Rusakova LI. Probl Tuberk Bolezn Legk; 2006 Nov; (8):33-7. PubMed ID: 17002056 [Abstract] [Full Text] [Related]
16. [Thiopoeitins in the treatment of tuberculosis]. Sinitsyn MV, Bogadel'nikova IV, Sokolova GB. Probl Tuberk Bolezn Legk; 2007 Nov; (4):21-5. PubMed ID: 17657963 [Abstract] [Full Text] [Related]
17. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis. Wang JY, Lee LN, Yu CJ, Chien YJ, Yang PC, Tami Group. Respirology; 2009 Sep; 14(7):1012-9. PubMed ID: 19659516 [Abstract] [Full Text] [Related]
19. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis. Park SK, Kim JH, Kang H, Cho JS, Smego RA. Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342 [Abstract] [Full Text] [Related]